Skip to main content
TipRanks
Go Ultimate75% OFF

Jacob May Insider Profile

4 Followers

Jacob May, owns more than 5% of security at Seelos Therapeutics, holds 5.71M shares in Seelos Therapeutics (Ticker: SEELQ). Most recently, Jacob May Sold 4,120,900 shares of Seelos Therapeutics on Jul 24, 2009 for an estimated value of $884.02K.

Jacob May's Trading History

SEELQ
Seelos Therapeutics
Jul 24, 2009owns more than 5% of securityInformative Sell884.02K―
SEELQ
Insider Shares: 5.71M (11.34%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 24, 2009Informative Sell$884.02K4,120,900$0.21-5.10%
Feb 18, 2009Informative Buy$86.83K610,363$0.14+82.30%
Jan 07, 2009Informative Buy$132.82K1,161,726$0.11+46.20%

You May Also Like

Jacob May insider profile FAQ

What is the percentage of profitable transactions made by Jacob May?
The percentage of profitable transactions made by Jacob May is 67%.
What is the average return per transaction made by Jacob May?
The average return per transaction made by Jacob May is 41.10%.
What stocks does Jacob May hold?
Jacob May holds: SEELQ stocks.
What was Jacob May’s latest transaction?
Jacob May’s latest transaction was an Informative Sell of $884.02K.
What was Jacob May's most profitable transaction?
Jacob May’s most profitable transaction was an Informative Buy of SEELQ stock on February 18, 2009. The return on the trade was 82.30%.
What is Jacob May's role in Seelos Therapeutics?
Jacob May's role in Seelos Therapeutics is owns more than 5% of security.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.